Anti-SARS-CoV-2 (COVID-19) Spike antibody (3525) was raised against a peptide corresponding to 20 amino acids near the carboxy terminus of SARS-CoV-2 (COVID-19) Spike glycoprotein. The immunogen is located within the last 50 amino acids of SARS-CoV-2 (COVID-19) Spike protein.
SARS-CoV-2 (COVID-19) Spike Antibody is supplied in PBS containing 0.02% sodium azide.
Formulierung:
Liquid
Application Verdünnung:
Optimal dilutions for each application to be determined by the researcher.
Anwendungsbeschreibung:
IHC: 1 µg/mL Antibody validated: Immunohistochemistry in COVID-19 patient samples. All other applications and species not yet tested.
Figure 2 ELISA Validation Coating Antigen: immunogen peptide, 3525P, 10 &956,g/mL, incubate at 4 &730,C overnight.Detection Antibodies: SARS-CoV-2 Spike antibody, 3525-biotin or 3525, dilution: 0.5-1000 ng/mL, incubate at RT for 1 hr. 3525-biotin was detected by HRP-conjugated streptavidin at 1:5,000 and 3525 was detected by anti-rabbit HRP conjugated secondary antibodies at 1:10,000 , incubate at RT for 1 hr.
Figure 1 Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) Spike in COVID-19 Patient Lung Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) spike antibody (3525-biotin, 2 &956,g/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT, antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4&730,C, following by streptavidin-HRP conjugate at 20 &956,g/mL. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 spike protein was observed in macrophages of COVID-19 patient lung, but not in non-COVID-19 patient lung.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
